Neurofilament light chain proteins are a sensitive biomarker of neuronal damage in cirrhotic patients with hepatic encephalopathy

NfL is a promising biomarker for HE. Its use in clinical practice may improve early detection and stratification of HE severity in cirrhotic patients.

Authors

Institutions

Publication Details

Journal
Frontiers in Molecular Biosciences
Published
2026-02-26
DOI
https://doi.org/10.3389/fmolb.2026.1744194
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neurofilament light chain proteins are a sensitive biomarker of neuronal damage in cirrhotic patients with hepatic encephalopathy

Clelia Asero, Teresa Maltese, Vincenzo Macaione, Maria Stella Franzè et al.
Frontiers in Molecular Biosciences
Liver Disease and Transplantation
article

Neurofilament light chain proteins are a sensitive biomarker of neuronal damage in cirrhotic patients with hepatic encephalopathy

Clelia Asero, Teresa Maltese, Vincenzo Macaione, Maria Stella Franzè, Irene Cacciola, Claudia Ligresti, Antonio Battaglia
article en

Abstract

NfL is a promising biomarker for HE. Its use in clinical practice may improve early detection and stratification of HE severity in cirrhotic patients.

Frontiers in Molecular BiosciencesVol. 13
University of Messina (IT), University of Palermo (AR)
Reduced inequalities
Openalex Percentile: Top 44%
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.